MoneyWorks4Me

The sales surged to Rs. 2875.48 millions, up 25.06% for the September 2022 quarter as against Rs. 2299.24 millions during the corresponding quarter previous year.Net profit for the quarter ended September 2022 increases to Rs. 240.22  millions from Rs. 238.53 millions.Operating Profit saw a handsome growth to 643.98 millions from 619.24 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 2875.48 2299.24 25.06 5590.70 4719.74 18.45 9880.90 8565.78 15.35
Other Income 75.45 73.49 2.67 149.35 137.17 8.88 417.16 231.28 80.37
PBIDT 643.98 619.24 4.00 1247.74 1189.34 4.91 2361.90 2036.24 15.99
Interest 239.84 241.97 -0.88 479.61 483.21 -0.75 955.33 1002.16 -4.67
PBDT 404.14 377.27 7.12 768.13 706.13 8.78 1389.65 1034.08 34.39
Depreciation 163.92 138.74 18.15 326.53 279.31 16.91 1309.70 872.92 50.04
PBT 240.22 238.53 0.71 441.60 426.82 3.46 79.95 161.16 -50.39
TAX 0.00 0.00 0.00 0.00 0.78 0.00 137.05 205.16 -33.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -109.17 94.76 -215.21
PAT 240.22 238.53 0.71 441.60 426.04 3.65 -57.10 -44.00 29.77
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 22.40 26.93 -16.85 22.32 25.20 -11.43 23.90 23.77 0.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..